Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filovirus”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Not applicableUnknownNCT05888649
What this trial is testing

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

Who this might be right for
Ebola Virus Disease
UL-PIRE Africa Center 1,500
Early research (Phase 1)Ended earlyNCT02041715
What this trial is testing

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802

Who this might be right for
Ebola Virus Infection
Arbutus Biopharma Corporation 21
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Early research (Phase 1)Study completedNCT00072605
What this trial is testing

Experimental Ebola Vaccine Trial

Who this might be right for
Hemorrhagic Fever, EbolaHealthy
National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableStudy completedNCT02658331
What this trial is testing

Evaluation of the FilmArray BioThreat-E Test

Who this might be right for
Ebola Virus Disease
BioMérieux 156
Not applicableStudy completedNCT02431923
What this trial is testing

Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,043
Early research (Phase 1)Study completedNCT03475056
What this trial is testing

CAd3-Marburg Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT02401373
What this trial is testing

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

Who this might be right for
Ebola Virus Disease
First Affiliated Hospital of Zhejiang University 61
Large-scale testing (Phase 3)Study completedNCT03161366
What this trial is testing

Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine

Who this might be right for
Ebola Virus Disease
Epicentre 500
Early research (Phase 1)Study completedNCT00646152
What this trial is testing

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

Who this might be right for
InfluenzaSevere Acute Respiratory Distress SyndromeSmallpox+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 57
Early research (Phase 1)Study completedNCT04906629
What this trial is testing

INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees

Who this might be right for
Ebola Virus Disease
University of Geneva, Switzerland 46
Testing effectiveness (Phase 2)Study completedNCT04385719
What this trial is testing

Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy

Who this might be right for
EbolaHIV/AIDS
Makerere University 24
Not applicableStudy completedNCT02911428
What this trial is testing

Open Study of the Duration of Immunity After Vaccination With GamEvac

Who this might be right for
Hemorrhagic Fever, Ebola
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60
Large-scale testing (Phase 3)WithdrawnNCT02307591
What this trial is testing

Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

Who this might be right for
Ebola Virus Disease
Emergency NGO Onlus
Testing effectiveness (Phase 2)Study completedNCT02876328
What this trial is testing

Partnership for Research on Ebola VACcinations

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,789
Early research (Phase 1)Study completedNCT02313077
What this trial is testing

A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 87
Early research (Phase 1)Study completedNCT03478891
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 19
Testing effectiveness (Phase 2)Study completedNCT03333538
What this trial is testing

Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo

Who this might be right for
Healthy Volunteers
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 220
Early research (Phase 1)Study completedNCT01353027
What this trial is testing

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc. 30
Early research (Phase 1)Study completedNCT02464670
What this trial is testing

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

Who this might be right for
Ebola Vaccine
Inovio Pharmaceuticals 240
Load More Results